Article
Bio-Techne's quarterly profit misses estimates as biotech funding woes persist
Rating:
0.0
Views:
36
Likes:
1
Library:
1
Bio-Techne missed Wall Street expectations for first-quarter profit on Tuesday, as a persisting funding crunch among its biotech clients weighed on demand for its diagnostic products and compounds used in developing drugs.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value